[Visual and neurological disturbances accompanying with pregnancies of hyperprolactinemic patients].
Twenty-three hyperprolactinemic infertile cases become pregnant after surgical treatment and/or bromocriptine administration, and 18 of them accomplished normal full-term deliveries. Serial ophthalmological examination which had been performed monthly throughout pregnancy revealed that four cases bearing pituitary adenomas developed visual disturbances which manifested themselves in the latter part of gestational period. The objective signs detected in these cases were bitemporal hemianopsia, temporal and nasal visual defects and the disappearance of central isopter. Another patient with microadenoma complained of headache at 16 weeks of gestation and it became more severe as gestation progressed. Bromocriptine (1.25 mg/day) was effective in diminishing this symptom. Although all these cases recovered from visual disturbances and headache after delivery, two of them were operated on transsphenoidally when radiological evidence of pituitary enlargement was found in the postpartum period. It is generally accepted that nearly 20% of hyperprolactinemic patients have pituitary adenomas. In view of the limited accuracy of techniques used in diagnosing pituitary tumor, it is legitimate to postulate that most hyperprolactinemic infertile patients have microadenoma to some extent. For this reason, a detailed follow up of visual field and neurological signs throughout pregnancy of hyperprolactinemic patients is important in early detection of changes in pituitary size.
D000236:Adenoma / Q000097:blood*; D000328:Adult; D005260:Female; D006801:Humans; D010911:Pituitary Neoplasms / Q000097:blood*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000097:blood*; D011388:Prolactin / Q000097:blood*; D014786:Vision Disorders / Q000097:blood* / Q000209:etiology
D011388:Prolactin